CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Neuroimaging Findings of CAR T-Cell-Associated Neurotoxicity: A Review.
Neuroimaging Findings of CAR T-Cell-Associated Neurotoxicity: A Review.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
CAR-T 细胞疗法在治疗难治性血液系统恶性肿瘤方面具有显著疗效。然而,CAR-T 疗法可能在某些患者中诱导神经毒性效应。神经毒性的常见症状范围从早期体征如头痛、意识模糊、谵妄和失语,到严重表现如癫痫发作、运动无力、颅内压增高、脑水肿和昏迷。磁共振成像(MRI)可为中枢神经系统结构、生理和功能所出现的异常提供宝贵见解。本综述旨在检视当前关于CAR-T 诱导神经毒性的脑MRI发现的文献,阐明其诊断能力、临床意义以及推进成像模式的新兴趋势。更好地理解CAR-T 神经毒性的神经相关因素,对于早期检测、制定神经保护策略以及优化CAR-T 方案以最大化疗效同时最小化不良神经毒性效应至关重要。
Chimeric antigen receptor T-cell (CAR-T) therapy has remarkable efficacy in treating refractory hematologic malignancies.
However, CAR-T therapy may induce neurotoxic effects in some patients. Common symptoms of neurotoxicity range from early signs such as headache, confusion, delirium, and aphasia to severe manifestations such as seizures, motor weakness, increased intracranial pressure, cerebral edema, and coma. Magnetic resonance imaging (MRI) can offer invaluable insight into resulting abnormalities in the structure, physiology, and function of the central nervous system.
This review aims to examine the current literature on brain MRI findings of CAR-T-induced neurotoxicity, elucidating its diagnostic capabilities, clinical implications, and emerging trends in advancing imaging modalities. An improved understanding of neural correlates of CAR-T neurotoxicity is important for early detection, development of neuroprotective strategies, and optimization of CAR-T regimens to maximize therapeutic efficacy while minimizing adverse neurotoxic effects.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。